Drug intelligence / Profile preview

[11C]MK-3168

Development stage
Phase 1
Lead developer
Merck
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

[11C]MK-3168 is a carbon-11 labeled radiopharmaceutical developed as a positron emission tomography (PET) tracer for imaging fatty acid amide hydrolase (FAAH) in the brain. FAAH is the primary enzyme responsible for the metabolic degradation of the endocannabinoid anandamide. By binding to FAAH, [11C]MK-3168 allows for the in vivo quantification of enzyme availability and distribution. This tracer is primarily used in clinical research to investigate alterations in the endocannabinoid system across various psychiatric conditions, including post-traumatic stress disorder (PTSD), alcohol use disorder, and psychosis. The tracer was originally developed by Merck and has been utilized in studies led by Yale University.

Other names
Carbon-11 MK-3168Carbon11 MK-3168Carbon 11 MK-3168
02

Targets

AcetylcholinesteraseFAAHPDE4 (Phosphodiesterase 4A1)

Beyond the preview

Go deeper on [11C]MK-3168.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [11C]MK-3168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call